Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
9.79M
-
Shares change
-
+3.74M
-
Total reported value, excl. options
-
$158M
-
Value change
-
+$59.9M
-
Number of buys
-
36
-
Number of sells
-
-8
-
Price
-
$16.10
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q2 2019
48 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q2 2019.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.79M shares
of 23.6M outstanding shares and own 41.45% of the company stock.
Largest 10 shareholders include Capital World Investors (1.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.18M shares), Polygon Management Ltd. (1M shares), MILLENNIUM MANAGEMENT LLC (768K shares), Cormorant Asset Management, LP (700K shares), Alphabet Inc. (699K shares), MARSHALL WACE, LLP (515K shares), Artal Group S.A. (500K shares), Capital International Investors (489K shares), and FMR LLC (374K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.